Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03015532 · ClinicalTrials.gov registry record · Phase 2
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
A Phase 2 study of Postoperative Pain, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 285
- Enrollment target
- 20
- Study locations
NCT03015532 is a Phase 2 study of Postoperative Pain that has completed, run by Heron Therapeutics. The registered enrollment target is 285 participants, above the 227-participant average among 63 other Postoperative Pain trials with a reported enrollment target (26% higher). The trial reports 20 study locations across 7 states.
The verdict
NCT03015532, a Phase 2 study of Postoperative Pain, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 285 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a Phase 2b, randomized, double-blind, saline placebo- and active-controlled, multicenter study in subjects undergoing primary unilateral total knee arthroplasty (TKA) to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of HTX-011 administered via infiltration to the surgical site.
Conditions Studied
Interventions
- DRUG Saline Placebo
- DRUG Ropivacaine
- DRUG HTX-011
- DRUG Bupivicaine HCl
Study Locations (20)
Texas
- - Bellaire
- - Houston
- - Houston
- - Houston
- - Plano
Florida
- - Miami
- - Miami
- - Miami
- - Tamarac
California
- - La Jolla
- - Riverside
- - San Diego
Ohio
- - Columbus
- - Columbus
- - Dayton
Alabama
- - Mobile
- - Sheffield
Arizona
- - Phoenix
- - Phoenix
Nevada
- - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2017-01-13 |
| Est. Completion | 2018-05-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03015532
The ClinicalTrials.gov registry entry for NCT03015532 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 63 other Postoperative Pain trials with a reported enrollment target (26% higher). The listed sponsor is Heron Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Saline Placebo is the first listed.
NCT03015532 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Texas, Florida, California.
Frequently Asked Questions
What is clinical trial NCT03015532 about?
NCT03015532 is a clinical study titled "Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia". This is a Phase 2b, randomized, double-blind, saline placebo- and active-controlled, multicenter study in subjects undergoing primary unilateral total knee arthroplasty (TKA) to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of HTX-011 administered via infiltration to the surgica...
What is the current status of trial NCT03015532?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 285 participants. The study started on 2017-01-13. Estimated completion is 2018-05-16.
What conditions does trial NCT03015532 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT03015532?
The interventions under investigation include: Saline Placebo (DRUG), Ropivacaine (DRUG), HTX-011 (DRUG), Bupivicaine HCl (DRUG).
Who is sponsoring clinical trial NCT03015532?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03015532 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
RECRUITING · Phase 2
-
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
RECRUITING · Phase 2
-
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
COMPLETED · Phase 2
-
Phase 2 Bunionectomy HTX-011 Administration Study
COMPLETED · Phase 2
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.